Abstract
ChatGPT has gained remarkable traction since its inception in November 2022. However, it faces limitations in generating inaccurate responses, ignoring existing guidelines, and lacking reasoning when applied in clinical settings. This study introduces ChatGPT-CARE, a tool that integrates clinical practice guidelines with ChatGPT, focusing on COVID-19 outpatient treatment decisions. By employing in-context learning and chain-of-thought prompting techniques, ChatGPT-CARE enhances original ChatGPT’s clinical decision support and reasoning capabilities. We created three categories of various descriptions of patients seeking COVID-19 treatment to evaluate the proposed tool, and asked two physicians specialized in pulmonary disease and critical care to assess the responses for accuracy, hallucination, and clarity. The results indicate that ChatGPT-CARE offers increased accuracy and clarity, with moderate hallucination, compared to the original ChatGPT. The proposal ChatGPT-CARE could be a viable AI-driven clinical decision support tool superior to ChatGPT, with potential applications beyond COVID-19 treatment decision support.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Revised Figure 1 to include more details about the method and illustration.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
